Harding L
Mood Institute, Milford, CT 06461, USA.
ArticleKetamine
Non-inferiority, comparative effectiveness study of intravenous ketamine v. intranasal esketamine for treatment-resistant depression: The EQUIVALENCE trial protocol.
ArticleKetamine
Health Care Resource Use and Medical Costs Among Patients With Major Depressive Disorder and Acute Suicidal Ideation or Behavior Initiated on Esketamine Nasal Spray or Traditional Treatments in the United States.
ArticleKetamine
Understanding profiles of patients with treatment-resistant depression by stringency of health plan prior authorization criteria for approval of esketamine nasal spray.
ArticleKetamine
Barriers to Esketamine Nasal Spray Treatment Among Adults With Treatment-Resistant Depression.
ArticleKetamine